This study will explore the possibility of using a molecular imaging technique to detect neurotransmitters released during performance of a cognitive task. The technique is currently used to examine chronic changes in binding potentials because the conventional methods are not suitable for detection of acute changes. We have recently demonstrated that the method can be modified to allow detection of acute changes. Using this modified method, we detected the release of striatal dopamine during performance of a motor planning task. The technique however requires further validation and testing before it can be reliably used to study human cognition. First two experiments will examine whether the modified technique generates false positive or false negative results. False positive effect will be tested using a control (no-activation) experiment which will not release dopamine. This experiment will also help us determine the range of 'normal' variation in the rate of ligand displacement. False negative results will be tested using an amphetamine challenge test. Because amphetamine is known to enhance striatal dopaminergic activity, the rate of ligand displacement should increase after the drug administration. The study will also evaluate whether the technique can be used to advance our understanding of human cognition. The evaluation will include examination of its ability to acquire information about the neurotransmission associated with a cognitive task. We propose to study a dopamine dependent task (implicit motor memory) to ensure that the modified technique is sensitive to isolate and detect striatal dopamine released during cognitive processing. The evaluation will also include examination of the ability of the technique to probe cognitive controversies. We propose to probe the controversy concerning striatal processing of nonprocedural memory tasks that are impaired following striatal lesions. Because these tasks do not consistently activate basal ganglia in neuroimaging studies, striatal involvement in the processing is unclear. Detection of striatal dopamine release in this experiment will support the findings of lesion studies and may indicate that, the striatal processing elicits sub-threshold hemodynamic response. A negative result will suggest nondopaminergic or extrastriatal processing of these tasks. This study will determine whether the molecular imaging technique can be reliably used to investigate an unexplored aspect (neurotransmission) of human cognition. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21MH073624-01
Application #
6900403
Study Section
Cognitive Neuroscience Study Section (COG)
Program Officer
Brady, Linda S
Project Start
2005-04-01
Project End
2007-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
1
Fiscal Year
2005
Total Cost
$196,800
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Blum, Kenneth; Modestino, Edward J; Badgaiyan, Rajendra D et al. (2018) Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse. EC Psychol Psychiatr 7:564-579
Blum, Kenneth; Han, David; Modestino, Edward J et al. (2018) A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. Subst Use Misuse 53:220-229
Blum, K; Jacobs, W; Modestino, E J et al. (2018) Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic. SEJ Surg Pain 1:1-11
Blum, Kenneth; Badgaiyan, Rajendra D; Dunston, Georgia M et al. (2018) The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans. Mol Neurobiol 55:5526-5536
Blum, Kenneth; Febo, Marcelo; Fried, Lyle et al. (2017) Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). J Reward Defic Syndr Addict Sci 3:3-13
Blum, Kenneth; Fried, Lyle; Madigan, Margaret A et al. (2017) Critical Analysis of White House Anti-Drug Plan. Glob J Addict Rehabil Med 1:
Blum, Kenneth; Simpatico, Thomas; Febo, Marcelo et al. (2017) Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs. Mol Neurobiol 54:3753-3758
Blum, Kenneth; Modestino, Edward J; Gondré-Lewis, Marjorie et al. (2017) ""Dopamine homeostasis"" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic. J Syst Integr Neurosci 3:
McLaughlin, Thomas; Han, David; Nicholson, James et al. (2017) Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone? J Syst Integr Neurosci 3:
Schoenthaler, Stephen J; Blum, Kenneth; Fried, Lyle et al. (2017) The effects of residential dual diagnosis treatment on alcohol abuse. J Syst Integr Neurosci 3:

Showing the most recent 10 out of 43 publications